“The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market.
The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market.
In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers.
The report has profiled the leading players of this market along with the developments (new product launches and partnerships, and joint ventures) by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the North America orthobiologics market.
The key players in the North America orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the orthobiologics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
This report provides information with regards to established firms as well as new entrants/smaller firms, and thereby gauges the pulse of the market; it in turn helps deduce the market shares.
The market strategies with regards to this market are (market penetration, product development/innovation, market development, market diversification, and competitive assessment).
The report provides insights on the following pointers:
• Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the North American orthobiologics market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of Product approvals and Product recalls.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the North America orthobiologics market across geographies, exploits new clientele base and different pricing policies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the North America orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market.
• Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop the business strategies and manufacturing capabilities of leading players, thereby enhancing the bottom line of the companies in the North America orthobiologics market.
• Product/ Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs.
”
“TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET SEGMENTATION & COVERAGE 11
1.3 STAKEHOLDERS 11
2 RESEARCH METHODOLOGY 12
2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET 13
2.2 ARRIVING AT THE NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE 13
2.2.1 TOP-DOWN APPROACH 13
2.2.2 BOTTOM UP APPROACH 14
2.2.3 MACRO INDICATOR-BASED APPROACH 15
2.3 ASSUMPTIONS 16
3 EXECUTIVE SUMMARY 18
4 MARKET OVERVIEW 20
4.1 INTRODUCTION 20
4.2 ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET 21
4.3 MARKET DRIVERS AND INHIBITORS 22
4.4 KEY MARKET DYNAMICS 23
5 ORTHOBIOLOGICS MARKET, BY PRODUCT 24
5.1 INTRODUCTION 25
5.2 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2013-2019 (USD MN) 26
5.3 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2013-2019 (USD MN) 27
5.4 NORTH AMERICA BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013-2019 (USD MN) 29
5.5 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY,
2013-2019 (USD MN) 30
5.6 NORTH AMERICA BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY COUNTRY, 2013-2019 (USD MN) 31
6 ORTHOBIOLOGICS MARKET, BY END USER 33
6.1 INTRODUCTION 34
6.2 NORTH AMERICA HOSPITALS MARKET 35
6.3 NORTH AMERICA ORTHOPEDIC CLINICS MARKET 36
6.4 NORTH AMERICA OTHER END-USERS MARKET 37
7 ORTHOBIOLOGICS MARKET, BY GEOGRAPHY 38
7.1 INTRODUCTION 39
7.2 U.S. ORTHOBIOLOGICS MARKET 40
7.2.1 U.S. ORTHOBIOLOGICS MARKET, BY PRODUCT 41
7.2.2 U.S. ORTHOBIOLOGICS MARKET, BY END-USER 43
7.3 CANADA ORTHOBIOLOGICS MARKET 44
7.3.1 CANADA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
7.3.2 CANADA ORTHOBIOLOGICS MARKET, BY END-USER 47
7.4 MEXICO ORTHOBIOLOGICS MARKET 48
7.4.1 MEXICO ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
7.4.2 MEXICO ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 50
8 ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE 52
8.1 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS 52
8.2 MERGERS & ACQUISITIONS 53
8.3 NEW PRODUCT LAUNCHES 54
8.4 AGREEMENTS 56
8.5 OTHER DEVELOPMENTS 56
9 ORTHOBIOLOGICS MARKET, BY COMPANY 57
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BIOMET, INC. 57
9.2 MEDTRONIC PLC 61
9.3 INTEGRA LIFESCIENCES CORPORATION 64
9.4 STRYKER CORPORATION 67
9.5 ZIMMER HOLDINGS, INC. 70
9.6 DEPUY SYNTHES COMPANIES (PART OF JOHNSON & JOHNSON FAMILY OF COMPANIES) 73
9.7 TORNIER, INC. 76
9.8 NUVASIVE, INC. 79
9.9 EXACTECH, INC. 81
9.10 GLOBUS MEDICAL, INC. 84
9.11 WRIGHT MEDICAL TECHNOLOGY, INC. 87
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 91
10.1 CUSTOMIZATION OPTIONS 91
10.1.1 REGULATORY FRAMEWORK 91
10.1.2 EPIDEMIOLOGY DATA 91
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 91
10.1.4 IMPACT ANALYSIS 91
10.2 RELATED REPORTS 92
10.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 93
10.3.1 RT SNAPSHOTS 94
“
“LIST OF TABLES
UU
TABLE 1 NORTH AMERICA ORTHOBIOLOGICS MARKET: MACRO INDICATOR, BY COUNTRY, 2011-2013 16
TABLE 2 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN) 21
TABLE 3 NORTH AMERICA ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS 22
TABLE 4 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY TYPE, 2013-2019 (USD MN) 23
TABLE 5 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 25
TABLE 6 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2013-2019 (USD MN) 27
TABLE 7 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2013-2019 (USD MN) 28
TABLE 8 NORTH AMERICA BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013-2019 (USD MN) 29
TABLE 9 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY,
2013-2019 (USD MN) 31
TABLE 10 NORTH AMERICA BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY COUNTRY, 2013-2019 (USD MN) 32
TABLE 11 NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY END USER,
2013-2019 (USD MN) 34
TABLE 12 NORTH AMERICA HOSPITALS MARKET, BY COUNTRY, 2013–2019 (USD MN) 35
TABLE 13 NORTH AMERICA ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013-2019 (USD MN) 36
TABLE 14 NORTH AMERICA OTHER END-USERS MARKET, BY COUNTRY, 2013-2019 (USD MN) 37
TABLE 15 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY GEOGRAPHY, 2013-2019 (USD MN) 39
TABLE 16 U.S. ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 42
TABLE 17 U.S. ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 43
TABLE 18 CANADA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
TABLE 19 MEXICO ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
TABLE 20 MEXICO ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 51
TABLE 21 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 52
TABLE 22 NORTH AMERICA ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS 53
TABLE 23 NORTH AMERICA ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES 54
TABLE 24 NORTH AMERICA ORTHOBIOLOGICS MARKET: AGREEMENTS 56
TABLE 25 NORTH AMERICA ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS 56
TABLE 26 BIOMET, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 58
TABLE 27 MEDTRONIC PLC: KEY FINANCIALS, 2009-2013 (USD MN) 61
TABLE 28 INTEGRA LIFESCIENCES CORPORATION: KEY FINANCIALS, 2010-2013 (USD MN) 64
TABLE 29 STRYKER CORPORATION: KEY FINANCIALS, 2009-2013 (USD MN) 67
TABLE 30 ZIMMER, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 71
TABLE 31 DEPUY SYNTHES COMPANIES: KEY FINANCIALS, 2011-2013 (USD MN) 74
TABLE 32 TORNIER, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 77
TABLE 33 NUVASIVE, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 79
TABLE 34 EXACTECH, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 81
TABLE 35 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009-2013 (USD MN) 85
TABLE 36 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011-2013 (USD MN) 87
“
“LIST OF FIGURES
FIGURE 1 NORTH AMERICA ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE 11
FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM 13
FIGURE 3 TOP-DOWN APPROACH 14
FIGURE 4 BOTTOM-UP APPROACH 15
FIGURE 5 MACRO INDICATOR-BASED APPROACH 16
FIGURE 6 NORTH AMERICA ORTHOBIOLOGICS MARKET SNAPSHOT 19
FIGURE 7 NORTH AMERICA ORTHOBIOLOGICS MARKET PRODUCT, BY COUNTRY,
2014 (USD MN) 23
FIGURE 8 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2014 & 2019 (USD MN) 25
FIGURE 9 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY,
2013-2019 (USD MN) 26
FIGURE 10 NORTH AMERICA STEM CELL THERAPY MARKET, BY COUNTRY, 2013-2019 (USD MN) 28
FIGURE 11 NORTH AMERICA BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013-2019 (USD MN) 29
FIGURE 12 NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY,
2013-2019 (USD MN) 30
FIGURE 13 NORTH AMERICA BONE GROWTH FACTOR AND SPINAL STIMULATION MARKET,
BY COUNTRY, 2013-2019 (USD MN) 32
FIGURE 14 NORTH AMERICA ORTHOBIOLOGICS MARKET, BY END USER, MARKET COMPARISON, 2014 & 2019 (USD MN) 34
FIGURE 15 NORTH AMERICA HOSPITALS MARKET, BY COUNTRY, 2013–2019 (USD MN) 35
FIGURE 16 NORTH AMERICA ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013-2019 (USD MN) 36
FIGURE 17 NORTH AMERICA OTHER END-USERS MARKET, BY COUNTRY, 2013-2019 (USD MN) 37
FIGURE 18 NORTH AMERICA ORTHOBIOLOGICS MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2013-2019 (USD MN) 39
FIGURE 19 U.S. ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 41
FIGURE 20 U.S. ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 41
FIGURE 21 U.S. ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 42
FIGURE 22 U.S. ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 43
FIGURE 23 U.S. ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 44
FIGURE 24 CANADA ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 44
FIGURE 25 CANADA ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 45
FIGURE 26 CANADA ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 46
FIGURE 27 CANADA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 47
FIGURE 28 CANADA ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 47
FIGURE 29 CANADA ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 48
FIGURE 30 MEXICO ORTHOBIOLOGICS MARKET, MARKET OVERVIEW, 2014 & 2019 (%) 48
FIGURE 31 MEXICO ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 49
FIGURE 32 MEXICO ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 50
FIGURE 33 MEXICO ORTHOBIOLOGICS MARKET, BY END-USER, 2013-2019 (USD MN) 50
FIGURE 34 MEXICO ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 51
FIGURE 35 NORTH AMERICA ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 52
FIGURE 36 BIOMET, INC.: REVENUE MIX, 2013 (%) 57
FIGURE 37 CONTRIBUTION OF SPINE, BONE HEALING, & MICROFIXATION SEGMENT TOWARDS COMPANY REVENUE, 2011-2013 (USD MN) 58
FIGURE 38 MEDTRONIC PLC: REVENUE MIX, 2013 (%) 61
FIGURE 39 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN) 62
FIGURE 40 INTEGRA LIFESCIENCES CORPORATION: REVENUE MIX, 2013 (%) 64
FIGURE 41 CONTRIBUTION OF U.S. SPINE & OTHER SEGMENT TOWARDS COMPANY REVENUE, 2010-2013 (USD MN) 65
FIGURE 42 STRYKER CORPORATION: REVENUE MIX, 2013 (%) 67
FIGURE 43 CONTRIBUTION OF RECONSTRUCTIVE SEGMENT TOWARDS COMPANY REVENUE, 2010-2013 (USD MN) 68
FIGURE 44 ZIMMER HOLDINGS, INC.: REVENUE MIX, 2013 (%) 70
FIGURE 45 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN) 71
FIGURE 46 DEPUY SYNTHES COMPANIES: REVENUE MIX, 2013 (%) 73
FIGURE 47 TORNIER, INC.: REVENUE MIX, 2013 (%) 76
FIGURE 48 CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUE,
2009-2013 (USD MN) 77
FIGURE 49 NUVASIVE, INC.: REVENUE MIX, 2013 (%) 79
FIGURE 50 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUE,
2009-2013 (USD MN) 80
FIGURE 51 EXACTECH, INC.: REVENUE MIX, 2013 (%) 81
FIGURE 52 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 82
FIGURE 53 GLOBUS MEDICAL, INC.: REVENUE MIX, 2013 (%) 84
FIGURE 54 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUE, 2009-2013 (USD MN) 85
FIGURE 55 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX, 2013 (%) 87
FIGURE 56 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUE,
2011-2013 (USD MN) 88
“
